Skip to main content
Skip to navigation

Latest podcasts

RegRapPod − September 2023

RegRapPod − July/August 2023

RegRapPod – June 2023

RegRapPod – May 2023

Regulating Vaxzevria

RegRapPod – April 2023

Regulatory Rapporteur - September 2023

RR-Sept-2023-Cover

September 2023 – Contents

AdobeStock_585476774

The worldwide web of regulation

Supply-Chain-Medicines

Q&A:
Navigating the
pharmaceutical supply chain

AdobeStock_572744272

Biosimilars CMC development considerations from the sponsor perspective

AdobeStock_209340094

Navigating the global supply of starting materials for cell-based therapies

AdobeStock_386873785

Regulatory considerations of a growing pharmaceutical company: a UK/US comparison of the generics industry

AdobeStock_414656141_Editorial_Use_Only (1)

Warning letters for direct-to-consumer advertising: a five-year retrospective analysis

September 2023 – Contents
The worldwide web of regulation
Q&A:
Navigating the
pharmaceutical supply chain
Biosimilars CMC development considerations from the sponsor perspective
Navigating the global supply of starting materials for cell-based therapies
Regulatory considerations of a growing pharmaceutical company: a UK/US comparison of the generics industry
Warning letters for direct-to-consumer advertising: a five-year retrospective analysis

Previous
Next